Powell, D. R., Smith, M. G., Doree, D. D., Harris, A. L., Xiong, W. W., Mseeh, F., . . . Ding, Z. (2015). LP-925219 maximizes urinary glucose excretion in mice by inhibiting both renal SGLT1 and SGLT2. Pharmacol Res Perspect.
Chicago-stil citatPowell, David R., et al. "LP-925219 Maximizes Urinary Glucose Excretion in Mice By Inhibiting Both Renal SGLT1 and SGLT2." Pharmacol Res Perspect 2015.
MLA-referensPowell, David R., et al. "LP-925219 Maximizes Urinary Glucose Excretion in Mice By Inhibiting Both Renal SGLT1 and SGLT2." Pharmacol Res Perspect 2015.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.